Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...

Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.

UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.

From Dupixent to Tezspire and verekitug, explore emerging sinusitis treatments and the race to improve chronic rhinosinusitis ...

Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 ...

Artificial intelligence (AI) is rapidly transforming the biotechnology landscape, and as it does, we are seeing more and more strategic collaborations and partnerships focused on the technology. These ...

Italy’s biotech ecosystem might be slightly smaller and less visible than some other European hubs, but it is home to a growing number of companies advancing ambitious therapeutic programs. From gene ...

A deficiency of dopamine: how does Parkinson’s disease affect the body? Unlike levodopa, which, when it reaches the brain gets converted to dopamine, the drug in question, tavapadon, activates ...

While non-exhaustive, this list offers an overview of the year’s biotech events taking place around the world, aimed at partnering and connecting with decision makers in biopharma. If there is a ...